Studies on subject under NRTI treatment regimen usually did show low CD4 levels associated with PN whereas later studies, omitting NRTIs and protease inhibitors, tend to show no association between CD4 counts and sensory neuropathies (Evans et al. 2011; Benevides et al. 2017). The gene discussed is CD4; the disease is Sensory neuropathy.